SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-22-068722
Filing Date
2022-11-02
Accepted
2022-11-02 17:02:11
Documents
1
Period of Report
2022-10-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 4  
1 OWNERSHIP DOCUMENT ownership.xml 4 3495
  Complete submission text file 0001213900-22-068722.txt   5009
Mailing Address C/O MARRONE BIO INNOVATIONS, INC. 2121 SECOND STREET, A-107 DAVIS CA 95618
Business Address
Marrone Pamela G (Reporting) CIK: 0001582885 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38105 | Film No.: 221355059

Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Issuer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations